Treatment of Co-Morbid Methamphetamine Substance Abuse and Borderline Personality Disorder Features Using Modified Dialectical Behavior Therapy
Date of Award
Doctor of Philosophy
Dr. Amy E. Naugle
Dr. C. Richard Spates
Dr. Scott T. Gaynor
Dr. Susan Baird
The study investigated the effectiveness of a time-limited, skills-based treatment in a population of female substance abusers. This project implemented a pilot clinical trial to evaluate the effectiveness of a 12-session modified Dialectical Behavior Therapy (DBT) protocol among a small sample of women, with co-morbid borderline personality disorder features, receiving concurrent outpatient treatment for methamphetamine abuse. A non-concurrent multiple baseline design was used. In addition to on-going assessment conducted during baseline and weekly over the course of treatment, a comprehensive assessment battery was administered pre-, and post-treatment as well as at 1 and 3 months following treatment. Findings suggest that notable improvements were made in several variables of interest among treatment completers and some non-completers. This study suggests that an abbreviated version of DBT, adapted to substance use and dependence issues, can be modestly effective for females with BPD features and MA dependence who demonstrate persistent attempts for change and mild to moderate symptoms of psychopathology. Clinical and research implications for DBT and substance use problems are discussed.
Schultz Fischer, Jessica R., "Treatment of Co-Morbid Methamphetamine Substance Abuse and Borderline Personality Disorder Features Using Modified Dialectical Behavior Therapy" (2007). Dissertations. 859.
5th Advisor: Dr. Roberto Flachier